Gene Review:
Krt13 - keratin 13
Mus musculus
Synonyms:
47 kDa cytokeratin, CK-13, CK13, Cytokeratin-13, K13, ...
- Changes in keratin expression during malignant progression of transformed mouse epidermal keratinocytes. Caulín, C., Bauluz, C., Gandarillas, A., Cano, A., Quintanilla, M. Exp. Cell Res. (1993)
- Changes in protein expression during multistage mouse skin carcinogenesis. Rundhaug, J.E., Gimenez-Conti, I., Stern, M.C., Budunova, I.V., Kiguchi, K., Bol, D.K., Coghlan, L.G., Conti, C.J., DiGiovanni, J., Fischer, S.M., Winberg, L.D., Slaga, T.J. Mol. Carcinog. (1997)
- Tissue-specific expression of murine keratin K13 in internal stratified squamous epithelia and its aberrant expression during two-stage mouse skin carcinogenesis is associated with the methylation state of a distinct CpG site in the remote 5'-flanking region of the gene. Winter, H., Rentrop, M., Nischt, R., Schweizer, J. Differentiation (1990)
- Differential expression of cytokeratin after orthotopic implantation of newly established human tongue cancer cell lines of defined metastatic ability. Morifuji, M., Taniguchi, S., Sakai, H., Nakabeppu, Y., Ohishi, M. Am. J. Pathol. (2000)
- Constitutive NF-kappaB activation, normal Fas-induced apoptosis, and increased incidence of lymphoma in human herpes virus 8 K13 transgenic mice. Chugh, P., Matta, H., Schamus, S., Zachariah, S., Kumar, A., Richardson, J.A., Smith, A.L., Chaudhary, P.M. Proc. Natl. Acad. Sci. U.S.A. (2005)
- Loss of expression of transforming growth factor beta in skin and skin tumors is associated with hyperproliferation and a high risk for malignant conversion. Glick, A.B., Kulkarni, A.B., Tennenbaum, T., Hennings, H., Flanders, K.C., O'Reilly, M., Sporn, M.B., Karlsson, S., Yuspa, S.H. Proc. Natl. Acad. Sci. U.S.A. (1993)
- The suprabasal expression of alpha 6 beta 4 integrin is associated with a high risk for malignant progression in mouse skin carcinogenesis. Tennenbaum, T., Weiner, A.K., Belanger, A.J., Glick, A.B., Hennings, H., Yuspa, S.H. Cancer Res. (1993)
- Extracellular matrix receptors and mouse skin carcinogenesis: altered expression linked to appearance of early markers of tumor progression. Tennenbaum, T., Yuspa, S.H., Grover, A., Castronovo, V., Sobel, M.E., Yamada, Y., De Luca, L.M. Cancer Res. (1992)
- Studies on immunity against Escherichia coli K13 with monoclonal anti-K13 and anti-anti-K13. Söderström, T., Ohman, L., Stein, K., Schneerson, R., Vann, W.F., Hanson, L.A. Infection (1985)
- Retinoic acid-induced normal and tumor-associated aberrant expression of the murine keratin K13 gene does not involve a promotor sequence with striking homology to a natural retinoic acid responsive element. Winter, H., Fink, P., Schweizer, J. Carcinogenesis (1994)
- The malignant capacity of skin tumours induced by expression of a mutant H-ras transgene depends on the cell type targeted. Brown, K., Strathdee, D., Bryson, S., Lambie, W., Balmain, A. Curr. Biol. (1998)
- Aberrant expression during two-stage mouse skin carcinogenesis of a type I 47-kDa keratin, K13, normally associated with terminal differentiation of internal stratified epithelia. Nischt, R., Roop, D.R., Mehrel, T., Yuspa, S.H., Rentrop, M., Winter, H., Schweizer, J. Mol. Carcinog. (1988)
- ras gene activation and aberrant expression of keratin K13 in ultraviolet B radiation-induced epidermal neoplasias of mouse skin. Sutter, C., Strickland, P.T., Mukhtar, H., Agarwal, R., Winter, H., Schweizer, J. Mol. Carcinog. (1993)
- Retinoic acid disintegrated desmosomes and hemidesmosomes in stratified oral keratinocytes. Hatakeyama, S., Hayashi, S., Yoshida, Y., Otsubo, A., Yoshimoto, K., Oikawa, Y., Satoh, M. J. Oral Pathol. Med. (2004)
- Therapeutic efficacy of the alpha-emitter 211At bound on microspheres compared with 90Y and 32P colloids in a murine intraperitoneal tumor model. Vergote, I., Larsen, R.H., de Vos, L., Nesland, J.M., Bruland, O., Bjørgum, J., Alstad, J., Tropé, C., Nustad, K. Gynecol. Oncol. (1992)
- Differentiation and tumor response to retinobenzoic acid RE-80 in a malignant conversion model. Kulesz-Martin, M.F., Lisafeld, B., Paterson, J., Driscoll, D., Shudo, K., Roop, D.R., Kisiel, N.D. Cancer Detect. Prev. (1995)
- Protective capacity of antibodies against Escherichia coli and K antigens. Kaijser, B., Ahlstedt, S. Infect. Immun. (1977)
- Low frequency of codon 61 Ha-ras mutations and lack of keratin 13 expression in 7,12-dimethylbenz[a]-anthracene-induced hamster skin tumors. Robles, A.I., Gimenez-Conti, I.B., Roop, D., Slaga, T.J., Conti, C.J. Mol. Carcinog. (1993)
- Arrangement of a cluster of three mouse type I keratin genes expressed sequentially during esophageal-type epithelial cell differentiation. Filion, M., Sarafian, V., Lussier, M., Bélanger, C., Lapointe, L., Royal, A. Genomics (1994)
- Aberrant in vitro expression of keratin K13 induced by Ca2+ and vitamin A acid in mouse epidermal cell lines. Sutter, C., Nischt, R., Winter, H., Schweizer, J. Exp. Cell Res. (1991)
- Early expression of type I K13 keratin in the progression of mouse skin papillomas. Gimenez-Conti, I., Aldaz, C.M., Bianchi, A.B., Roop, D.R., Slaga, T.J., Conti, C.J. Carcinogenesis (1990)
- v-Ha-ras-induced mouse skin papillomas exhibit aberrant expression of keratin K13 as do their 7,12-dimethylbenz[a]anthracene/12-O-tetradecanoylphorbol-13-acetate -induced analogues. Sutter, C., Strickland, J.E., Welty, D.J., Yuspa, S.H., Winter, H., Schweizer, J. Mol. Carcinog. (1991)